NO992724D0 - Pharmaceutical mixtures containing N-sulfonyl-indoline derivatives - Google Patents

Pharmaceutical mixtures containing N-sulfonyl-indoline derivatives

Info

Publication number
NO992724D0
NO992724D0 NO992724A NO992724A NO992724D0 NO 992724 D0 NO992724 D0 NO 992724D0 NO 992724 A NO992724 A NO 992724A NO 992724 A NO992724 A NO 992724A NO 992724 D0 NO992724 D0 NO 992724D0
Authority
NO
Norway
Prior art keywords
sulfonyl
mixtures containing
indoline derivatives
pharmaceutical mixtures
pharmaceutical
Prior art date
Application number
NO992724A
Other languages
Norwegian (no)
Other versions
NO992724L (en
Inventor
Jean-Claude Gautier
Simon John Fuller
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of NO992724D0 publication Critical patent/NO992724D0/en
Publication of NO992724L publication Critical patent/NO992724L/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
NO992724A 1996-12-05 1999-06-04 Pharmaceutical mixtures containing N-sulfonyl-indoline derivatives NO992724L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9614957A FR2756736B1 (en) 1996-12-05 1996-12-05 PHARMACEUTICAL COMPOSITIONS CONTAINING N-SULFONYL INDOLINE DERIVATIVES
PCT/FR1997/002210 WO1998024430A1 (en) 1996-12-05 1997-12-04 Pharmaceutical compositions containing n-sulphonyl indolin derivatives

Publications (2)

Publication Number Publication Date
NO992724D0 true NO992724D0 (en) 1999-06-04
NO992724L NO992724L (en) 1999-06-04

Family

ID=9498376

Family Applications (1)

Application Number Title Priority Date Filing Date
NO992724A NO992724L (en) 1996-12-05 1999-06-04 Pharmaceutical mixtures containing N-sulfonyl-indoline derivatives

Country Status (25)

Country Link
EP (1) EP0941090A1 (en)
JP (1) JP2000507618A (en)
KR (1) KR20000069308A (en)
CN (1) CN1239887A (en)
AR (1) AR009651A1 (en)
AU (1) AU716575B2 (en)
BR (1) BR9712406A (en)
CA (1) CA2273990A1 (en)
CO (1) CO4910129A1 (en)
DZ (1) DZ2362A1 (en)
EE (1) EE9900206A (en)
FR (1) FR2756736B1 (en)
HU (1) HUP0001386A3 (en)
ID (1) ID23373A (en)
IL (1) IL129936A0 (en)
IS (1) IS5062A (en)
MY (1) MY132819A (en)
NO (1) NO992724L (en)
NZ (1) NZ335750A (en)
RU (1) RU2174394C2 (en)
SK (1) SK75599A3 (en)
TR (1) TR199901702T2 (en)
WO (1) WO1998024430A1 (en)
YU (1) YU23099A (en)
ZA (1) ZA9710919B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2786486B3 (en) * 1998-11-16 2000-12-08 Sanofi Sa PROCESS FOR THE PREPARATION OF (2S) -1 - [(2R, 3S) -5-CHLORO-3- (2- CHLOROPHENYL) -1- (3,4-DIMETHOXY BENZENESULFONYL) -3-HYDROXY- 2,3-DIHYDRO- 1H-INDOLE-2-CARBONYL] PYRROLIDINE-2-CARBOXAMIDE, ITS SOLVATES AND / OR HYDRATES
DE19913692A1 (en) * 1999-03-25 2000-09-28 Basf Ag Mechanically stable pharmaceutical dosage forms containing liquid or semi-solid surface-active substances
US6437006B1 (en) 1999-09-27 2002-08-20 American Cyanamid Company Pharmaceutical carrier formulation
DE60028754T2 (en) 1999-11-12 2007-05-31 Abbott Laboratories, Abbott Park SOLID DISPERSION WITH RITONAVIR, FENOFIBRATE OR GRISEOFULVIN
FR2805992A1 (en) * 2000-03-08 2001-09-14 Sanofi Synthelabo Oral administration of N-sulfonyl-indoline derivative to treat central nervous system, cardiovascular or gastric disorders, using polyethylene glycol, polysorbate and poloxamer as solubilizers for high bioavailability
DE10026698A1 (en) 2000-05-30 2001-12-06 Basf Ag Self-emulsifying active ingredient formulation and use of this formulation
ITMI20011338A1 (en) * 2001-06-26 2002-12-26 Farmatron Ltd ORAL PHARMACEUTICAL COMPOSITIONS WITH IMMEDIATE RELEASE OF THE ACTIVE INGREDIENT
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
UA119324C2 (en) * 2013-04-02 2019-06-10 Теміс Медікер Лімітед Compositions of pharmaceutical actives containing diethylene glycol monoethyl ether or other alkyl derivatives
KR102139339B1 (en) * 2013-06-24 2020-07-29 주식회사 엘지생활건강 Cosmetic composition which has improved solubility comprising indole compound
KR102139338B1 (en) * 2013-06-24 2020-07-29 주식회사 엘지생활건강 Cosmetic composition which has improved solubility comprising indole compound

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3237814A1 (en) * 1982-10-12 1984-04-12 Warner-Lambert Co., 07950 Morris Plains, N.J. WATER-FREE EMULSIONS AND USE THEREOF
FR2679903B1 (en) * 1991-08-02 1993-12-03 Elf Sanofi DERIVATIVES OF N-SULFONYL INDOLINE CARRYING AN AMIDIC FUNCTION, THEIR PREPARATION, THE PHARMACEUTICAL COMPOSITIONS CONTAINING SAME.

Also Published As

Publication number Publication date
RU2174394C2 (en) 2001-10-10
MY132819A (en) 2007-10-31
CA2273990A1 (en) 1998-06-11
ID23373A (en) 2000-04-20
EE9900206A (en) 1999-12-15
CO4910129A1 (en) 2000-04-24
BR9712406A (en) 1999-08-31
IL129936A0 (en) 2000-02-29
AU716575B2 (en) 2000-03-02
ZA9710919B (en) 1999-06-04
NZ335750A (en) 2001-06-29
EP0941090A1 (en) 1999-09-15
HUP0001386A2 (en) 2001-04-28
FR2756736B1 (en) 1999-03-05
TR199901702T2 (en) 1999-09-21
IS5062A (en) 1999-06-01
AU5326298A (en) 1998-06-29
NO992724L (en) 1999-06-04
JP2000507618A (en) 2000-06-20
SK75599A3 (en) 2000-08-14
AR009651A1 (en) 2000-04-26
WO1998024430A1 (en) 1998-06-11
KR20000069308A (en) 2000-11-25
FR2756736A1 (en) 1998-06-12
CN1239887A (en) 1999-12-29
YU23099A (en) 1999-11-22
HUP0001386A3 (en) 2002-03-28
DZ2362A1 (en) 2002-12-28

Similar Documents

Publication Publication Date Title
DE69735712D1 (en) ARYL-PYRIMIDINE DERIVATIVES
DK0891332T3 (en) 6-phenylpyridyl-2-amine derivatives
DK0783302T3 (en) drugs
NO985539D0 (en) Pharmaceutical surface mixtures
NO981946D0 (en) Imidazoquinazolin derivatives
DE69737936D1 (en) DRUG
DE69732576D1 (en) TETRAHYDROBENZINDOLON DERIVATIVES
BR9610214A (en) Pharmaceutical compounds
DE69700887T2 (en) Isoprene derivatives
NO992724D0 (en) Pharmaceutical mixtures containing N-sulfonyl-indoline derivatives
ID16781A (en) PHARMACEUTICAL FORMULATIONS
NO994619L (en) Pharmaceutical mixtures
IS5026A (en) 2-methoxyphenylpiperazine derivatives
BR9507768A (en) Pharmaceutical composition
NO20003141D0 (en) Pharmaceutical mixtures
ID18698A (en) PHARMACEUTICAL COMPOSITION
NO961589D0 (en) Pharmaceutical mixtures
NO985084D0 (en) Vial
ITMI962628A0 (en) PHARMACEUTICAL COMPOSITION
NO965448D0 (en) Pharmaceutical compounds
IT1272935B (en) PHARMACEUTICAL COMPOSITION CONTAINING N-ACETYL-CISTEIN
DE29618094U1 (en) Pharmaceutical preparation
SE9600141D0 (en) Pharmaceutical formulation
SE9601854D0 (en) Pharmaceutical composition
SE9604299D0 (en) Pharmaceutical composition

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application